PATENT CLAIM ANALYSIS

Application Number: 16217839
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "490000"]

Abstract:
A tamper-resistant pharmaceutical dosage form comprising a multitude of particles which comprise a pharmacologically active compound, a polyalkylene oxide, and a disintegrant; wherein the pharmacologically active compound is dispersed in a matrix comprising the polyalkylene oxide and the disintegrant; wherein the content of the disintegrant is more than 5.0 wt.-%, based on the total weight of the pharmaceutical dosage form and/or based on the total weight of the particles; wherein the content of the polyalkylene oxide is at least 25 wt.-%, based on the total weight of the pharmaceutical dosage form and/or based on the total weight of the particles; and wherein the dosage form provides under in vitro conditions immediate release of the pharmacologically active compound in accordance with Ph. Eur.

Claim (Index 13):
The dosage form according to  claim 11 , wherein the pharmaceutical dosage form comprises dex-amphetamine or its respective pharmaceutically acceptable salts as pharmaceutically active compound.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 98.0
- Lexical Diversity: 2.57692
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15169778', '14287512', '15166573', '15673781', '14661639']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7173748672670113
- 35 USC 102 Novelty (BERT): 0.5002849606190918
- Combined Prediction Score: 0.6956658766022193
- Mean Citation Score: 226.473946
- Max Citation Score: 260.51462000000004
- Similarity Product: 197.96272374836929

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test